Sotera Health Company SHC

18.34 (0.11) (0.60%) as of 25 Sep
Market cap
$5.3B
P/E
32.1×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
321.38 280.05 303.44 311.31

+8 more quarters

Revenue Growth
9.18% 10.03% 4.56% 9.05%
Cost of Revenue
143.41 132.98 137.52 133.75
Gross Profit
177.96 147.07 165.92 177.56
SG&A Expenses
68.16 68.21 57.51 63.29
Operating Income
106.79 75.83 105.38 111.18
Non-operating Interest Expenses
34.41 34.75 35.05 39.15
Non-operating Income/Expense
(28.74) (33.21) (34.89) (38.24)
EBT
78.05 42.61 70.50 72.94
Income Tax Provision
24.41 16.02 35.65 24.54
Income after Tax
53.64 26.59 34.85 48.40
Net Income Common
53.64 26.59 34.84 48.40
EPS (Basic)
0.19 0.09 0.12 0.17
EPS (Diluted)
0.19 0.09 0.12 0.17
Shares (Basic, Weighted)
285.77 284.89 283.96 284.07
Shares (Diluted, Weighted)
288.15 287.62 286.42 286.75
Gross Margin
55.38% 52.52% 54.68% 57.04%
EBIT Margin
33.23% 27.08% 34.73% 35.71%
EBT margin
24.29% 15.22% 23.23% 23.43%
Net Profit Margin
16.69% 9.49% 11.48% 15.55%
EBITDA
141.82 108.11 139.39 140.84
EBIT
106.79 75.83 105.38 111.18
Income from Continuous Operations
53.64 26.59 34.85 48.40
Consolidated Net Income/Loss
53.64 26.59 34.85 48.40
EPS (Basic, from Continuous Ops)
0.19 0.09 0.12 0.17
EPS (Diluted, from Cont. Ops)
0.19 0.09 0.12 0.17
EPS (Basic, Consolidated)
0.19 0.09 0.12 0.17
EPS (Diluted, Consolidated)
0.19 0.09 0.12 0.17
Shares (Diluted, Average)
288.15 287.62 287.55 286.75
EBITDA Margin
44.13% 38.60% 45.94% 45.24%
Operating Cash Flow Margin
27.54% 10.51% 33.98% 22.86%

Fold the line items

In millions of $ except per-share values · columns are period end dates